Holding(s) in Company

RNS Number : 9245H

Synairgen plc

27 March 2020

 

Synairgen plc

("Synairgen" or the "Company")

Southampton, UK , : Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, announces that it was informed on 27 March 2020 that Leonard Licht, a private investor, now holds 9,720,000 ordinary shares of 1 pence  each in the capital of the Company, representing 8.88% of the Company's issued share capital.

Enquiries:

Synairgen plc	[phone]
Richard Marsden (Chief Executive Officer) John Ward (Finance Director)
finnCap - nominated adviser and broker	[phone]
Geoff Nash / Kate Bannatyne / Charlie Beeson (Corporate Finance) Alice Lane / Manasa Patil (ECM)
Consilium Strategic Communications - financial media and investor relations adviser	[phone]
Mary-Jane Elliott / Sue Stuart / Olivia Manser

 

END

 

 

HOLFLFLEVAIDFII